scispace - formally typeset
B

Brian Cox

Researcher at University of Sussex

Publications -  123
Citations -  2636

Brian Cox is an academic researcher from University of Sussex. The author has contributed to research in topics: Catalysis & Squalene. The author has an hindex of 27, co-authored 122 publications receiving 2479 citations. Previous affiliations of Brian Cox include The Hertz Corporation & University of Bristol.

Papers
More filters
Journal ArticleDOI

Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.

TL;DR: It is shown that retigabine acts as a KCNQ potassium channel opener, and it is likely that M-current modulation can explain the anticonvulsant actions of retIGabine in animal models of epilepsy.
Journal ArticleDOI

New Heteroannulation Reactions of N-Alkoxybenzamides by Pd(II) Catalyzed C-H Activation

TL;DR: A new palladium(II) catalyzed methodology for the direct synthesis of alkylidene isoindolinones from N-alkoxybenzamides is presented and both systems were found to tolerate a wide range of functionality.
Journal ArticleDOI

Batch versus Flow Photochemistry: A Revealing Comparison of Yield and Productivity

TL;DR: A broad range of synthetic photochemical transformations were optimized in both reactor modes and their yields and productivities compared and it was revealed that the productivity of flow reactors varied very little to that of their batch counterparts when the key reaction parameters were matched.
Journal ArticleDOI

HTS approaches to voltage-gated ion channel drug discovery

TL;DR: The authors describe the current technologies available for voltage-gated ion-channel screening, their application to HTS campaigns and the current limitations and emerging technologies within this area.
Journal ArticleDOI

Drug block of the hERG potassium channel: Insight from modeling

TL;DR: A KcsA‐based model was refined by rotating the four copies of the S6 transmembrane helix half a residue position toward the C‐terminus, so as to place all residues known to be involved in drug binding in positions lining the central cavity to produce complexes that are consistent with mutagenesis data for smaller, but not larger, ligands.